PEP
39
-9
INTC
41
4
DIS
85
3
FFIV
66
-4
O
17
-13
IR
63
-3
NEE
54
7
CAH
48
-6
NAVI
52
-2
DGX
48
11
EBAY
42
-2
HUM
41
-4
GLW
45
-3
CAG
24
-3
MSFT
48
-9
WMB
68
2
EXC
54
3
MRK
17
-5
IPG
34
-9
PYPL
52
-2
PEP
39
-9
INTC
41
4
DIS
85
3
FFIV
66
-4
O
17
-13
IR
63
-3
NEE
54
7
CAH
48
-6
NAVI
52
-2
DGX
48
11
EBAY
42
-2
HUM
41
-4
GLW
45
-3
CAG
24
-3
MSFT
48
-9
WMB
68
2
EXC
54
3
MRK
17
-5
IPG
34
-9
PYPL
52
-2
Financhill
Back

DoubleLine Opportunistic Bond ETF Vs. Neurogene Industry Stock Comparison

Buy
52

DBND
DoubleLine Opportunistic Bond ETF

Last Price:
45.66
Seasonality Move:
3.21%
Sell
1

NGNE
Neurogene

Last Price:
34.67
Seasonality Move:
50.43%
Buy
52
DoubleLine Opportunistic Bond ETF (DBND) is a Buy

Is DoubleLine Opportunistic Bond ETF a Buy, Sell or Hold?

  • The current DoubleLine Opportunistic Bond ETF [DBND] share price is $45.66. The Score for DBND is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
  • DBND is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
1
Neurogene (NGNE) is a Sell

Is Neurogene a Buy, Sell or Hold?

  • The current Neurogene [NGNE] share price is $34.52. The Score for NGNE is 1, which is 98% below its historic median score of 50, and infers higher risk than normal.
  • NGNE is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

DBND Stock Price Chart

What is DoubleLine Opportunistic Bond ETF's stock price today?

  • The DoubleLine Opportunistic Bond ETF share price today is $45.66
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DBND is experiencing buying pressure, which is a positive indicator for future bullish movement.

NGNE Stock Price Chart

What is Neurogene's stock price today?

  • The Neurogene share price today is $34.52
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NGNE is experiencing selling pressure, which indicates risk of future bearish movement.

DBND Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.26 Sell
Relative Strength Index (14 RSI): 37.14 Sell
Chaikin Money Flow: 38381 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (45.69 - 46.35) Sell
Bollinger Bands (100): (45.75 - 47.11) Sell

NGNE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.55 Sell
Relative Strength Index (14 RSI): 35.74 Sell
Chaikin Money Flow: -452975 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (41.4 - 61.5) Sell
Bollinger Bands (100): (34.32 - 50.52) Sell

DBND Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 45.68 Sell
20-day SMA: 45.88 Sell
50-day SMA: 46.59 Sell
200-day SMA: 45.88 Sell
8-day EMA: 45.7 Sell
20-day EMA: 45.92 Sell
50-day EMA: 46.26 Sell
200-day EMA: 46.04 Sell

NGNE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 53.3 Sell
20-day SMA: 51.47 Sell
50-day SMA: 46.76 Sell
200-day SMA: 38.99 Sell
8-day EMA: 47.13 Sell
20-day EMA: 50.2 Sell
50-day EMA: 47.47 Sell
200-day EMA: 38.44 Sell

DoubleLine Opportunistic Bond ETF Earnings Growth & DBND Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Neurogene Earnings Growth & NGNE Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.90 per share.

DoubleLine Opportunistic Bond ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Neurogene Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):